|Heywood|Rheumatism|Research and Development|Research and Development|Research and Development|Iroundation|||||
|---|---|---|---|---|---|---|---|---|---|
|Legal and|a~tive||information|||||||
||President|||||Dr THotherssB||||
||Chairman|||||Profsuor ABHssseH (resigued|||14th Sept2021)|
|||||||Dr ZPaskius (appomted|14th Sept 2021)|||
||Vice||Chairman|||MrsIStevenson||||
||Secretary|||||Mrs1 Brause||||
||Treasurer|||||Mr RA Orossley||||
|||||||lvir JSRewley||||
|||||||Mr DD O'Neill||||
|||||||Mrs H C Duffy||||
|||||||Mr RA Crossley||||
||Charity number|||||||||
||Address of|||Charity||Staft'~ Rheumatology||Centre||
|||||||Hayao cd Hospital||||
|||||||KgbLstte||||
|||||||Burshm||||
|||||||Stokeon-Tusut||||
|||||||ST6JAG||||
||Independent|||Examiner||Hastier Tweddle of||||
|||||||Dean Statham Chartered Accouutauts||||
|||||||29King Street||||
|||||||Newcastle-Under-Lyme||||
|||||||Statfardshhe||||
|||||||ST5 JBR||||
||Bankers|||||Natwcrt Baskpic||||
|||||||2Market Street||||
|||||||Length||||
|||||||Stoke.on-Trent||||
|||||||Staffordshire||||
|||||||ST32HW||||
||Solicitors|||||LLP||||
|||||||The Butmpton||||
|||||||Newcastle-Under-Lyme||||
|||||||Statftrdshire||||
|||||||ST50()W||||
||Investment|||Advisors||Charles Stanley 4CoLtd||||
|||||||55Bishopgate||||
|||||||London||||
|||||||BC2N3AS||||





## 

|Trustem' Report||
|---|---|
|Independent<br>Exammer's|Report|
|Statement ofFhancial|Activities|
|Bahmce Sheet||
|Statement ofCashflows||
|Notes tctheF~Statements||





## 

## 

## 

|President|Dr THotherssH|||
|---|---|---|---|
||Professor ABHassell(resigned||14th Sept2021)|
||DrZPaskins (appomtui|14th|Sept 2021)|
|Vice Chairman|Mrs KStevenson|||
|Secretary|Mrs JBranny|||
|Treasurer|MrRA Crossley|||
||MrJSRowley|||
||MrD D O'Neill|||
||Mrs H CDufly|||
||MrRA Ckossley|||



## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 




## 

## 

## 

## 

## 



## 

## 

## 

|||||Unrestricted|Total Funds|Total Funds|
|---|---|---|---|---|---|---|
||||Note|Funds|2022|2021|
|Income|||||||
|||||6/77|6,377|11/57|
|||||10,000|10,000|38,826|
|Invesnnent<br>mcome:|||||||
|Income &om listed fixed|asset mvestments||2|113,562|113,562|91,038|
|Total income||||129,939|129,939|141~1|
|Expenditure|||||||
|Costs ofraising funds:|||||||
|Investment<br>management|costs|||23@12|23,912|20,932|
|Expenditure<br>on charitable||activities|3|302,106|302106|195/24|
|Total expenditure||||326,018|326,018|216P56|
|Net (expenditure)/<br>income||||(196,079)|(196,079)|(75,035)|
|Transfers|||||||
|Transfers between fimds|||||||
|Net (expenditure)/<br>income||before|||||
|gains and losses on mvestments||||(196,079)|(196,079)|(75,035)|
|Net gams/(losses)<br>on mvestonmts||||(162@24)|(162924)|1053877|
|Net movement<br>in funds|||7|(359,003)|(359,003)|978,842|
|Reconciliation ofPanda|||||||
|Balances brought<br>forward|at I April 2021||7|4,191,162|4,191,162|3@12/20|
|Balances cerned forward|at|31March 2022|7|3,832,159|3,832,159|4,191,162|





## 

||Note|2022||2021||
|---|---|---|---|---|---|
|Fixed assets||||||
|Investments||3,806,884|||4,066,457|
|Current assets||||||
|Debtors<br>Cash atbank and iu hand|5|4,483<br>89@76|10,164<br>121,725|||
|||94,459|131,889|||
|Creditors:||||||
|amounts falling due within one year|6|69,184|7,184|||
|Net current assets||||||
||||||124,705|
|Total assets less current habiTitles||3,832,159|||4,191,162|
|Net assets||3,832,159|||4,191,162|
|||3,832,159|||4,191,162|
|||3,832,159|||4,191,162|







## 

## 

||||2022|||
|---|---|---|---|---|---|
|||Note||||
|Net cash generated from||||||
|operating<br>activities||10||(241961)|(242,069)|
|Cash flow from investing|activities|||||
|Interest snd dividends<br>Proceoth from sale ofmvestmeuts<br>Purchase ofmvestments||||113462<br>~25<br>(545,675)|91,038<br>383/51<br>(274,330)|
|Net change in cash and cash equivalents||||(31,749)|(42,010)|
|Cash and cash equivalents|at1April 2021|||121,725|163,735|
|Cash and cash equivalents|at31March 2022|||89976|121,725|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 




## 

|Not|es tothe Accounts|fo|r the yea|r ended 31Marc|h 2022||||
|---|---|---|---|---|---|---|---|---|
||'||||||||
|3|e<br>o|Charitable||Activities|||||
|||||||Reslncted|Total|Total|
|||||||Fends|2022|2021|
|||||||8|8||
||Costs ofcharitable||activities||||||
||Grants paid (see|detailed schedule below)|||289490||289790|187312|
||PIERcosts||||1318||1,318||
||Video project|||||||4,550|
||Website design||||2400||2/00||
||Frontiine dance||||417||417|750|
||Tai chi classes||||733||733||
||Versus<br>rthritis||||5,518||5,518||
||Jayex digital signage||||486||486|486|
||Support costs||||||||
||Accountancy<br>fees||||1,920||1,920|1,919|
||Sundry expanses||||224||224|307|
||||||302,106||302,106|195/24|
||Grants Payable||||||||
||||||||Total|Total|
||||||||2022|2021|
||Payroll grants||||||||
||Keele University||||172,409||172,409|131+90|
||UHNMT||||5,164||5,164|18,120|
||Other||||||||
||Keele University|research|||73,717||73,717||
||Beth Johnson Foundation||||38,000||38,000|37,902|
||Total grant paid||||289/90||289@90|187312|





## 

## 

|a~|||||
|---|---|---|---|---|
||||2022|2021|
|Cost orvaluation|||||
|Market value at 1April <br>Additions<br>atcost<br>Disposal proceeds<br>Realised gains/(losses)<br>Unreslised<br>gains/(losses)|2021<br>on disposals<br>on revaluations||4,066,457<br>545,675<br>(642325)<br>(4,452)<br>(158,471)|3,121,601<br>274830<br>(383351)<br>76,737<br>977,140|
|Market value at 31March||2022|3,806,884|4,066,457|
|||||2021|
|Portfolio valuation|||||
|-Securities|||3,806,884|4,066,457|
||||3,806,884|4,066,457|
|Realised gains on disposah|||||
|||||2021|
|||||f,|
|value ofdispose<br>Disposal proceeds|||646,777<br>(642325)|306,614<br>(383,351)|
|Net realised gates/(losses)|||(4,452)|76,737|





## 

## 

## 

|ebtors|||
|---|---|---|
|||2021|
|Prepayments<br>and Accrued income|||
|Prepaid expenses<br>Charles Stanley accrued mterest<br>Legacy|4,483|4,483<br>3,181<br>2,500|
||4,483|10,164|






## 

## 

## 

||||2021|
|---|---|---|---|
|Net movement<br>m funds||(359,003)|978,842|
|investment<br>mcome||(113/62)|(91,038)|
|Lossesl(gams)<br>on mvestm(mts||162924|(1,053,877)|
|Decrease/(mcrease)<br>in debtors||5,680|(2,597)|
|Increase/(decrease)<br>in creditors||62,000|(73/99)|
|Net cash used in operating|activities|(241961)|(242,069)|



